Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

44.71
Delayed Data
As of May 26
 +0.76 / +1.73%
Today’s Change
36.76
Today|||52-Week Range
45.84
+16.40%
Year-to-Date

Today’s Trading

Previous close43.95
Today’s open43.92
Day’s range43.83 - 44.85
Volume8,624,069
Average volume (3 months)7,242,972
Market cap$77.6B
Dividend yield2.37%
Data as of 4:01pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-47.25%
Earnings growth (this year)+12.43%
Earnings growth (next 5 years)+10.95%
Revenue growth (last year)+2.20%
P/E ratio50.2
Price/Sales2.73
Price/Book3.21

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk-0.18-0.43%
AGNAllergan-1.24-0.55%
AZNAstraZeneca-0.49-1.43%
LLYEli Lilly and Co-0.29-0.37%
Data as of 4:02pm ET, 05/26/2017

Financials

Next reporting dateJuly 19, 2017
EPS forecast (this quarter)$0.61
Annual revenue (last year)$20.9B
Annual profit (last year)$1.4B
Net profit margin5.06%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Executive VP-Finance
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts